StoneX Group’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,300
Closed -$1.12K 551
2023
Q1
$1.12K Sell
20,300
-57,423
-74% -$3.14K ﹤0.01% 421
2022
Q4
$396 Buy
+77,723
New +$3.82K ﹤0.01% 577

StoneX Group's LVACW Position: Q2 2023 in Review

StoneX Group sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 20,300 shares — an estimated $1.12K sold.

StoneX Group first reported a position in LVACW in Q4 2022 and held it in 2 quarters. The position peaked at $1.12K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • StoneX Group reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • StoneX Group sold 20,300 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $1.12K.
  • StoneX Group first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2022 and held it in 2 quarters.
  • StoneX Group's LAVA Medtech Acquisition Corp. Warrants position peaked at $1.12K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on StoneX Group's 13F filing for Q2 2023, filed 14 Aug 2023.